Procter & Gamble vs Colgate-Palmolive: Q1 Earnings Show Clear Leader
Procter & Gamble (PG) reported fiscal Q3 2026 revenue of $21.235 billion and core EPS of $1.59. Colgate-Palmolive (CL) followed with Q1 2026 adjusted EPS of $0.97 on revenue of $5.324 billion. The comparison highlights PG's scale advantage, while CL remains a solid dividend payer.
Key Numbers
Procter & Gamble (NYSE:PG) and Colgate-Palmolive (NYSE:CL) both reported quarterly earnings, reigniting the debate among dividend investors. PG posted fiscal Q3 2026 revenue of $21.235 billion and core EPS of $1.59, while CL reported Q1 2026 adjusted EPS of $0.97 on revenue of $5.324 billion. No immediate stock reaction was reported.
Key Financial Results
| Company | Revenue | EPS |
|---|---|---|
| Procter & Gamble (PG) | $21.235B | $1.59 (core) |
| Colgate-Palmolive (CL) | $5.324B | $0.97 (adjusted) |
Note: YoY comparisons were not provided in the source.
Earnings Highlights
PG cited strong performance in personal care and home care segments, while CL emphasized market share gains in emerging markets. No further details were disclosed.
Guidance
Neither company provided forward guidance in the reported release.
Impact on Stock
PG's solid results are likely to reinforce investor confidence in its dividend growth trajectory. CL may continue to attract income-focused investors seeking reliable payouts.
What This Means for Investors
PG offers greater scale and diversification, while CL provides focused exposure to oral and personal care. The choice depends on whether investors prioritize stable growth or higher dividend yields.
Frequently Asked Questions
Found this useful? Share it